Monopar Therapeutics Quarterly Common Stock, Shares Authorized from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Monopar Therapeutics quarterly Common Stock, Shares Authorized history and growth rate from Q4 2016 to Q3 2024.
  • Monopar Therapeutics Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 40M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40M 0 0% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 40M 0 0% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 40M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 40M 0 0% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 40M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 40M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 40M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 40M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 40M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 40M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 40M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 40M 0 0% Dec 31, 2021 10-K 2023-03-23
Q3 2021 40M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 40M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 40M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 40M 0 0% Dec 31, 2020 10-K 2022-03-24
Q3 2020 40M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 40M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 40M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 40M 0 0% Dec 31, 2019 10-K 2021-03-25
Q3 2019 40M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 40M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 40M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 40M 0 0% Dec 31, 2018 10-K 2020-03-27
Q3 2018 40M Sep 30, 2018 10-Q 2018-11-09
Q2 2018 40M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 40M Mar 31, 2018 10-Q 2018-05-11
Q4 2017 40M 0 0% Dec 31, 2017 10-K 2019-02-26
Q4 2016 40M Dec 31, 2016 10-K 2018-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.